Axogen Inc
For the period ended Dec 31, 2023. Filed Mar 5, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 5, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
AXOGEN, INC
/s/ Karen Zaderej
Karen Zaderej
Chief Executive Officer, President and Chairman of the Board
March 5, 2024
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Karen Zaderej (with full power to act alone), as his or her true and lawful attorney-in-fact and agent, with full powers of substitution and re-substitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to the Annual Report on Form 10-K of Axogen, Inc., and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite or necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or their substitute or substitutes, lawfully do or cause to be done by virtue hereof.
In accordance with the Exchange Act, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| /s/ Karen Zaderej | March 5, 2024 |
|---|---|
| Karen Zaderej, Chief Executive Officer, President and Chairman of the Board(Principal Executive Officer) | |
| /s/ Nir Naor | March 5, 2024 |
| Nir Naor, Chief Financial Officer(Principal Financial and Accounting Officer) | |
| /s/ William P. Burke | March 5, 2024 |
| William P. BurkeDirector | |
| /s/ Gregory G. Freitag | March 5, 2024 |
| Gregory G. FreitagDirector | |
| /s/ Joseph A. Tyndall | March 5, 2024 |
| Joseph A. TyndallDirector | |
| /s/ John H. Johnson | March 5, 2024 |
| John H. JohnsonDirector | |
| /s/ Adam M. Levine | March 5, 2024 |
| Alan M. LevineDirector | |
| /s/ Guido J. Neels | March 5, 2024 |
| Guido J. NeelsDirector | |
| Paul G. Thomas | March 5, 2024 |
| Paul G. ThomasDirector | |
| /s/ Amy Wendell | March 5, 2024 |
P112
| Amy WendellDirector | March 5, 2024 |
|---|---|
| /s/ Kathy Weiler | |
| Kathy WeilerDirector | March 5, 2024 |
P113
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.